Chemours Introduces Track & Trace Technology to Provide Real-Time Visibility into Ti-Pure™ TiO2 Order and Delivery Status

State-of-the-art technology empowers Ti-Pure™ Flex and Connect customers with improved visibility and supply reliability

The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, today announced the launch of Track & Trace, an innovative order tracking technology that provides Ti-Pure™ Flex and Connect customers with real-time visibility into their order location and status directly from the eCommerce portals.

This state-of-the-art technology provides step-by-step shipment updates, empowering Ti-Pure™ customers with improved visibility and supply reliability. Similar to consumer eCommerce delivery tracking, Ti-Pure™ Flex and Connect customers are now armed with up-to-the-minute delivery information that adds transparency and efficiency to their supply chain and production processes.

“Chemours Titanium Technologies is committed to customer-centered innovation, and that extends beyond our product portfolio to every aspect of the customer experience, including logistics and final-mile delivery,” said Aditya Beri, VP of Titanium Technologies Supply Chain & Minerals at Chemours. “With Track & Trace, our Ti-Pure™ Flex and Connect customers can operate with greater clarity and confidence when it comes to pigment deliveries, which is critical in today’s environment where supply chain issues can cause ripple effects across industries.”

Track & Trace is launching as a beta version—which will continue to be optimized over time—and includes global ocean tracking and road/truck monitoring in North America and Europe. In addition, customers can access Track & Trace directly through their Ti-Pure™ Flex and Connect portals. The introduction of this new solution is the latest example of Chemours’ investment in digital and automation tools that can drive efficiency and customer value. Other examples include artificial intelligence-based product forecasts, digitized supply chain planning solutions, drone warehouse management technology, and more.

“Reliability of supply has emerged as a competitive advantage for our customers. As a leading supplier of TiO₂ solutions, providing our customers with that edge requires that we have the industry’s most efficient and innovative end-to-end supply chain. We’re continually looking to elevate this standard by implementing new technology that benefits our customers,” said Christopher Young, Director of Titanium Technologies Supply Chain at Chemours. “We’re thrilled with the progress our supply chain and logistics teams have made in pursuing this goal and look forward to seeing how Track & Trace benefits our customers around the globe.”

About The Chemours Company

The Chemours Company (NYSE: CC) is a global leader in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemistry-based innovations. We deliver customized solutions with a wide range of industrial and specialty chemicals products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and consumer electronics, general industrial, and oil and gas. Our flagship products are sold under prominent brands such as Ti-Pure™, Opteon™, Freon™, Teflon™, Viton™, Nafion™, and Krytox™. The company has approximately 6,600 employees and 29 manufacturing sites serving approximately 2,900 customers in approximately 120 countries. Chemours is headquartered in Wilmington, Delaware and is listed on the NYSE under the symbol CC.

For more information, we invite you to visit chemours.com or follow us on Twitter @Chemours or LinkedIn.

Forward-Looking Statements

This press release contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to a historical or current fact. The words "believe," "expect," "will," "anticipate," "plan," "estimate," "target," "project" and similar expressions, among others, generally identify "forward-looking statements," which speak only as of the date such statements were made. These forward-looking statements may address, among other things, the outcome or resolution of any pending or future environmental liabilities, the commencement, outcome or resolution of any regulatory inquiry, investigation or proceeding, the initiation, outcome or settlement of any litigation, changes in environmental regulations in the U.S. or other jurisdictions that affect demand for or adoption of our products, anticipated future operating and financial performance for our segments individually and our company as a whole, business plans, prospects, targets, goals and commitments, capital investments and projects and target capital expenditures, plans for dividends or share repurchases, sufficiency or longevity of intellectual property protection, cost reductions or savings targets, plans to increase profitability and growth, our ability to make acquisitions, integrate acquired businesses or assets into our operations, and achieve anticipated synergies or cost savings, all of which are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Forward-looking statements are based on certain assumptions and expectations of future events that may not be accurate or realized. These statements are not guarantees of future performance. Forward-looking statements also involve risks and uncertainties that are beyond Chemours' control. In addition, the current COVID-19 pandemic has significantly impacted the national and global economy and commodity and financial markets, which has had and we expect will continue to have a negative impact on our financial results. The full extent and impact of the pandemic is still being determined and to date has included significant volatility in financial and commodity markets and a severe disruption in economic activity. The public and private sector response has led to travel restrictions, temporary business closures, quarantines, stock market volatility, and interruptions in consumer and commercial activity globally. Matters outside our control have affected our business and operations and may or may continue to hinder our ability to provide goods and services to customers, cause disruptions in our supply chains, adversely affect our business partners, significantly reduce the demand for our products, adversely affect the health and welfare of our personnel or cause other unpredictable events. Additionally, there may be other risks and uncertainties that Chemours is unable to identify at this time or that Chemours does not currently expect to have a material impact on its business. Factors that could cause or contribute to these differences include the risks, uncertainties and other factors discussed in our filings with the U.S. Securities and Exchange Commission, including in our Annual Report on Form 10-K for the year ended December 31, 2022. Chemours assumes no obligation to revise or update any forward-looking statement for any reason, except as required by law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230215005083/en/